Agilon Health, Inc. (NYSE:AGL – Get Free Report)’s stock price gapped down prior to trading on Tuesday. The stock had previously closed at $116.75, but opened at $111.94. Agilon Health shares last traded at $113.8950, with a volume of 36,491 shares traded.
Analyst Upgrades and Downgrades
AGL has been the subject of several research reports. Robert W. Baird set a $116.00 target price on Agilon Health in a research note on Thursday, August 6th. Benchmark reissued a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Sanford C. Bernstein raised shares of Agilon Health from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $86.00 to $125.00 in a research note on Tuesday, September 15th. StoneX increased their target price on shares of Agilon Health from $140.00 to $145.00 and gave the company a “buy” rating in a report on Wednesday, November 11th. Finally, Truist Financial set a $112.00 target price on shares of Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $107.38.
Check Out Our Latest Analysis on Agilon Health
Agilon Health Stock Down 0.8%
The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.06. The stock has a 50 day simple moving average of $91.28 and a 200 day simple moving average of $69.46. The firm has a market capitalization of $1.95 billion, a PE ratio of -20.87 and a beta of 3.10.
Agilon Health (NYSE:AGL – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $1.97 earnings per share for the quarter, beating analysts’ consensus estimates of ($1.23) by $3.20. Agilon Health had a negative return on equity of 51.97% and a negative net margin of 1.45%. The firm had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.46 billion. As a group, sell-side analysts forecast that Agilon Health, Inc. will post -1.87 earnings per share for the current year.
Institutional Investors Weigh In On Agilon Health
Several institutional investors have recently added to or reduced their stakes in AGL. Goldman Sachs Group Inc. purchased a new stake in Agilon Health during the 3rd quarter valued at $52,206,000. State Street Corp purchased a new position in shares of Agilon Health in the second quarter valued at about $30,024,000. Marshall Wace LLP bought a new position in shares of Agilon Health during the third quarter valued at about $22,141,000. Rubicon Founders LLC bought a new position in shares of Agilon Health during the second quarter valued at about $11,290,448. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Agilon Health by 9.5% during the second quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after purchasing an additional 3,074 shares during the period.
Agilon Health Company Profile
Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients’ health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.
Recommended Stories
- Five stocks we like better than Agilon Health
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
